Healthcare provider profile · identity verified

Jeffrey Landsman, MD

Geriatric Medicine · BALTIMORE, MD · NPI 1982636601

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	832	234
Rosuvastatin Calcium	Rosuvastatin Calcium	686	203
Amlodipine Besylate	Amlodipine Besylate	576	176
Levothyroxine Sodium	Levothyroxine Sodium	429	122
Lisinopril	Lisinopril	355	102
Metoprolol Succinate	Metoprolol Succinate	318	96
Losartan Potassium	Losartan Potassium	315	88
Pantoprazole Sodium	Pantoprazole Sodium	294	89
Hydrochlorothiazide	Hydrochlorothiazide	223	61
Metformin Hcl	Metformin Hcl	212	64
Eliquis	Apixaban	191	41
Sertraline Hcl	Sertraline Hcl	188	50
Escitalopram Oxalate	Escitalopram Oxalate	171	52
Omeprazole	Omeprazole	167	48
Gabapentin	Gabapentin	131	43
Tamsulosin Hcl	Tamsulosin Hcl	121	43
Meloxicam	Meloxicam	115	44
Synthroid	Levothyroxine Sodium	115	29
Pravastatin Sodium	Pravastatin Sodium	110	32
Simvastatin	Simvastatin	109	27
Albuterol Sulfate Hfa	Albuterol Sulfate	108	36
Metoprolol Tartrate	Metoprolol Tartrate	106	31
Lorazepam	Lorazepam	103	30
Famotidine	Famotidine	101	30
Allopurinol	Allopurinol	99	29
Ezetimibe	Ezetimibe	92	34
Trazodone Hcl	Trazodone Hcl	92	28
Clopidogrel	Clopidogrel Bisulfate	87	32
Bupropion Xl	Bupropion Hcl	84	22
Montelukast Sodium	Montelukast Sodium	83	24
Alprazolam	Alprazolam	82	19
Atenolol	Atenolol	82	21
Clonazepam	Clonazepam	82	12
Buspirone Hcl	Buspirone Hcl	79	26
Carvedilol	Carvedilol	77	25
Metformin Hcl Er	Metformin Hcl	71	25
Xarelto	Rivaroxaban	70	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	19
Furosemide	Furosemide	63	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	12
Fluticasone Propionate	Fluticasone Propionate	61	23
Telmisartan	Telmisartan	57	15
Doxycycline Hyclate	Doxycycline Hyclate	55	47
Myrbetriq	Mirabegron	55	14
Olmesartan Medoxomil	Olmesartan Medoxomil	55	12
Potassium Chloride	Potassium Chloride	55	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	53
Citalopram Hbr	Citalopram Hydrobromide	54	14
Jardiance	Empagliflozin	54	15
Ozempic	Semaglutide	52	suppressed
Mirtazapine	Mirtazapine	51	20
Fluoxetine Hcl	Fluoxetine Hcl	50	15
Valsartan	Valsartan	50	13
Donepezil Hcl	Donepezil Hcl	47	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	46	36
Zolpidem Tartrate	Zolpidem Tartrate	46	16
Venlafaxine Hcl Er	Venlafaxine Hcl	44	11
Duloxetine Hcl	Duloxetine Hcl	43	13
Spironolactone	Spironolactone	41	16
Irbesartan	Irbesartan	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	38	12
Esomeprazole Magnesium	Esomeprazole Magnesium	37	13
Finasteride	Finasteride	37	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Triamcinolone Acetonide	Triamcinolone Acetonide	35	24
Methylprednisolone	Methylprednisolone	33	31
Nifedipine Er	Nifedipine	33	11
Tramadol Hcl	Tramadol Hcl	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Entresto	Sacubitril/Valsartan	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Prednisone	Prednisone	31	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Azithromycin	Azithromycin	25	22
Ramipril	Ramipril	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Glipizide	Glipizide	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Baclofen	Baclofen	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Ketoconazole	Ketoconazole	19	15
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	12
Valacyclovir	Valacyclovir Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Amoxicillin	Amoxicillin	16	14
Digoxin	Digoxin	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Propranolol Hcl	Propranolol Hcl	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Xiidra	Lifitegrast	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Diazepam	Diazepam	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Bystolic	Nebivolol Hcl	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Linzess	Linaclotide	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error